TGF - β Signaling Pathway
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Cytotoxic T Cells-mediated Immune Response
Tumor Immunotherapy
The JAK-STAT Signaling Pathway
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Oct 31, 2025

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
Tal Goldberger1, Abraham Zlotogorski1
1Department of Dermatology, Hadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Jerusalem, Israel.
No abstract available in PubMed .